Editorial: Primary cilia as therapeutic targets

Front Mol Biosci. 2023 Oct 26:10:1322873. doi: 10.3389/fmolb.2023.1322873. eCollection 2023.

Yuhei Nishimura^{1

2}, Masaki Saito³, Wataru Otsu⁴, Keiko Miyadera⁵

¹ Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
² Mie University Research Center for Cilia and Diseases, Tsu, Mie, Japan.
³ Department of Molecular Physiology and Pathology, School of Pharma-Sciences, Teikyo University, Tokyo, Japan.
⁴ Department of Biomedical Research Laboratory, Gifu Pharmaceutical University, Gifu, Japan.
⁵ Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, United States.

No abstract available

Keywords: atopic dermatitis; cancer; gene therapy; inherited retinal degeneration; obesity; preeclampsia; primary cilia; therapeutic target.

Publication types

The authors declare that no financial support was received for the research, authorship, and/or publication of this article.